Home/Filings/4/0001076542-17-000095
4//SEC Filing

ROSELLINI MICHAEL 4

Accession 0001076542-17-000095

CIK 0001416172other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 1:49 PM ET

Size

13.1 KB

Accession

0001076542-17-000095

Insider Transaction Report

Form 4
Period: 2017-06-23
Transactions
  • Conversion

    Common Stock

    2017-06-23+104,890821,890 total
  • Conversion

    Common Stock

    2017-06-23+102,000702,000 total(indirect: By IRA)
  • Other

    Warrants

    2017-06-23617,0000 total
    From: 2016-12-02Exp: 2019-12-02Common Stock (104,890 underlying)
  • Other

    Warrants

    2017-06-23600,0000 total(indirect: By IRA)
    From: 2016-12-02Exp: 2019-12-02Common Stock (102,000 underlying)
Footnotes (5)
  • [F1]Shares held by the Michael Rosellini ROTH IRA. Dr. Rosellini has the sole power to vote and dispose of the shares held by the Michael Rosellini ROTH IRA.
  • [F2]Warrants held by the Michael Rosellini ROTH IRA. Dr. Rosellini has the sole power to vote and dispose of the warrants/shares held by the Michael Rosellini ROTH IRA.
  • [F3]On March 21, 2017, the Company offered to current warrant holders who participated in the 2016 Private Placement which closed on December 2, 2016, the opportunity to convert their warrants into common stock of the Company on the following terms ("Warrant Conversion Offer"). The offer terms included the exercise of seventeen (17) warrants for seventeen (17) shares of the Company's common stock at an exercise price of $0.01 per share for every one hundred (100) warrants owned. The remaining eighty-three (83) warrants per hundred warrants owned would be cancelled. The offer was on an all-or-nothing basis to convert all warrants held by each warrant holder.
  • [F4]Pursuant to the terms of the Warrant Conversion Offer, on June 23, 2017, of the 617,000 warrants held by Dr. Rosellini individually, 104,890 warrants were converted into 104,890 shares of common stock, and 512,110 warrants were cancelled.
  • [F5]Pursuant to the terms of the Warrant Conversion Offer, on June 23, 2017, of the 600,000 warrants held by the Michael Rosellini ROTH IRA, 102,000 warrants were converted into 102,000 shares of common stock and 498,000 warrants were cancelled.

Issuer

NEXEON MEDSYSTEMS INC

CIK 0001416172

Entity typeother

Related Parties

1
  • filerCIK 0001693434

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 1:49 PM ET
Size
13.1 KB